Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates

Details for Australian Patent Application No. 2007201700 (hide)

Owner Kirin Beer Kabushiki Kaisha Hematech, LLC

Inventors Ferguson, Stacy E; Tomizuka, Kazuma; Robl, James M; Kuroiwa, Yoshimi; Osborne, Barbara A.; Ishida, Isao; Goldsby, Richard A

Agent Griffith Hack

Pub. Number AU-A-2007201700

Parent 2001297523

Filing date 17 April 2007

Wipo publication date 10 May 2007

International Classifications

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/04 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - from milk

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

3 May 2007 Complete Application Filed

10 May 2007 Application Open to Public Inspection

  Published as AU-A-2007201700

14 August 2008 Assignment before Grant

  Kirin Beer Kabushiki Kaisha; Hematech, LLC The application has been assigned to Kirin Pharma Kabushiki Kaisha

26 March 2009 Assignment before Grant

  Kirin Pharma Kabushiki Kaisha The application has been assigned to Kyowa Hakko Kirin Co., Ltd.

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007201701-Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists

2007201699-Method of treating malignancies through induction of blood immune responses